Post Time: 2025-07-18
Error: No content files found.Eli Lilly, a leading US pharmaceutical company, is gearing up to launch its groundbreaking diabetes and obesity smart slim keto acv gummies medication, Tirzepatide—commercially known as Mounjaro—in India by 2025. The drug has garnered widespread attention for its efficacy in addressing both type 2 diabetes and obesity. With marketing authorizations already secured, the company is now working through final regulatory approvals before gnc keto gummies introducing this innovative solution to the Indian market. #weightloss #mounjaro pro burn keto acv gummies #health #fitness #news18 News18 Mobile App -